AI assistant
Sending…
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2012
Dec 19, 2012
32130_dirs_2012-12-19_bc7b3b4d-7c2f-4b1e-9aff-e861ec9c608b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2012-12-18
Reporting Person: COFFMAN ROBERT (Chief Scientific Officer & VP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-18 | Common Stock | M | 19926 | $1.50 | Acquired | 57918 | Direct |
| 2012-12-18 | Common Stock | F | 10451 | $2.86 | Disposed | 47467 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-18 | Stock Option | $1.50 | M | 19926 | Disposed | 2013-01-21 | Common Stock (19926) | Direct |
Footnotes
F1: On December 18, 2012, Dr. Coffman exercised certain of his outstanding options to purchase 19,926 shares. As consideration for the purchase price, Dr. Coffman delivered 10,451 shares to the Company. No shares were sold in the market in connection with this exercise.
F2: This Stock Option was granted on January 22, 2003 with an expiration of January 21, 2013 and vested over a four-year period after the date of the grant.
F3: Not applicable.
More from DYNAVAX TECHNOLOGIES CORP
Director's Dealing
2026
Feb 11
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10